Article

Decline in Varicella-Related Ambulatory Visits and Hospitalizations in the United States Since Routine Immunization Against Varicella

Division of Infectious Diseases, The Children's Hospital of Philadelphia, Philadelphia, PA, USA.
The Pediatric Infectious Disease Journal (Impact Factor: 3.14). 11/2009; 29(3):199-204. DOI: 10.1097/INF.0b013e3181bbf2a0
Source: PubMed

ABSTRACT Widespread varicella vaccination has led to substantial decreases in varicella-related mortality and hospitalizations. The effect of the vaccine on ambulatory care utilization is poorly defined.
To determine trends in varicella-related ambulatory care and hospital discharges before and after vaccine licensure.
Estimates of varicella-related ambulatory and hospital discharges were calculated for the pre- (1993-1995) and post- (1996-2004) vaccine licensure periods using the National Ambulatory Medical Care Survey, National Hospital Ambulatory Medical Care Survey, and National Hospital Discharge Survey.
Ambulatory and hospital discharge rates for varicella.
The rate of varicella-related ambulatory discharges decreased by 66% from 106.6 per 100,000 (95% confidence interval [CI]: 80.5-132.6) in the prelicensure period to 36.4 per 100,000 population (95% CI: 29.3-43.5) in the post-licensure period (P < 0.001). The decrease was significant across all age groups <45 years, with the greatest reduction (98%) occurring among patients 0 to 4 years of age. The incidence of varicella-related hospital discharges decreased by 53% from 30.9 per 100,000 (95% CI: 24.4-37.3) to 14.5 per 100,000 population (95% CI: 12.1-16.8; P < 0.001). This difference was significant among patients <14 years of age. Rates of varicella-related ambulatory discharges decreased significantly for both whites and non-whites in the postlicensure period, but postlicensure ambulatory discharge rates remained higher for non-whites than for whites. Decreases in varicella-related hospital discharges were statistically significant for whites and non-whites. Racial differences in the incidence of varicella-related hospital discharges also persisted following vaccine licensure.
Varicella-related ambulatory visits and hospitalizations have decreased significantly in the period after licensure of the varicella vaccine.

Download full-text

Full-text

Available from: Sarah Wood, Apr 07, 2015
1 Follower
 · 
68 Views
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Varicella is a highly contagious disease caused by primary infection with varicella zoster virus (VZV). VZV infection, as well as varicella vaccination, induces VZV-specific antibody and T-cell-mediated immunity, essential for recovery. The immune responses developed contribute to protection following re-exposure to VZV. When cell-mediated immunity declines, as occurs with aging or immunosuppression, reactivation of VZV leads to herpes zoster (HZ). It has been almost 20 years since universal varicella vaccination has been implemented in many areas around the globe and this has resulted in a significant reduction of varicella-associated disease burden. Successes are reviewed here, whilst emphasis is put on the challenges ahead. Most countries that have not implemented routine childhood varicella vaccination have chosen to vaccinate high-risk groups alone. The main reasons for not introducing universal vaccination are discussed, including fear of age shift of peak incidence age and of HZ incidence increase. Possible reasons for not observing the predicted increase in HZ incidence are explored. The advantages and disadvantages of universal vs targeted vaccination as well as different vaccination schedules are discussed.
    03/2014; 2(2):39-55. DOI:10.1177/2051013613515621
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Live attenuated vaccines to prevent varicella and zoster have been available in the US for the past 17 years, with a resultant dramatic decrease in varicella incidence and a predicted future decrease in the incidence of zoster. The pathogenesis and immune responses to varicella zoster virus (VZV) as well as the safety and effectiveness of VZV vaccines are reviewed. The lack of sterilizing immunity provided by VZV vaccines has not prevented them from being safe and effective. Virological and pathological information concerning parallels and differences between VZV and herpes simplex virus (HSV) are highlighted. Although VZV and HSV are distinct pathogens, they appear to have similarities in target organs and immunity that provide an expectation of a high likelihood for the success of vaccination against HSV, and predicted to be similar to that of VZV.
    Virology 01/2013; 435(1):29-36. DOI:10.1016/j.virol.2012.10.006 · 3.28 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The small unit operations/situation awareness system (SUO/SAS) was developed by the Defense Advanced Research Project Agency (DARPA) to address the future needs of individual soldiers on an increasingly complex and lethal battlefield. As tactical operations have shifted toward smaller units, the importance of force multipliers has concomitantly increased. One such force multiplier is the ability of a soldier operating in a restricted environment to constantly know the location of both friendly and enemy soldiers. The SUO/SAS geolocation system was designed to provide continuous reliable geolocation data in the many different restrictive environments which might be encountered by a soldier in modern warfare. This system integrates multiple sensors to provide a continuous solution in multiple environments. For open environments, the geolocation system may rely on GPS. But for those areas (such as inside a building) where GPS signals are nut available, a combination of other sensors are provided. Range measurements are provided by time-of-arrival (TOA) transceivers, and altitude information is provided by a barometric altimeter. Velocity is maintained via an IMU, and heading information is provided by a digital magnetic compass. All of this information is integrated into a single navigation Kalman filter to provide an optimal solution. This paper presents the architecture of the SUO/SAS geolocation system and characterization testing results.
    Military Communications Conference, 2003. MILCOM 2003. IEEE; 11/2003